The synthetic biology opportunity in the Nats’ crosshairs

The synthetic biology opportunity in the Nats’ crosshairs
(Image: Getty)
Peter Griffin
In the lead-up to last year’s general election, the National Party clearly signalled a regulatory shakeup in biotechnology was on the cards should it be able to form a government.The reasoning was that New Zealand was missing out on significant opportunities for economic growth and limited in its ability to develop biotech solutions to help tackle climate change because we’d stifled innovation in synthetic biology, where some of the biggest advances were being achieved elsewhere. Other than GE-freeree activists and their suppor...

More Opinion

Benchmark-beaters: how ESG gives indexers active power
Opinion

David Chaplin: Benchmark-beaters: how ESG gives indexers active power

The ESG push among institutional investors is changing the mix.

Has ArborGen finally crossed the Rubicon?
Opinion

Paul McBeth: Has ArborGen finally crossed the Rubicon?

Long-suffering shareholders might be dubious about the emerging green shoots.

Paul McBeth 02 Jul 2024
Our nation of tinkerers
Opinion

Simon Robertson: Our nation of tinkerers

From wine to Wētā, New Zealanders are always excelling at something.  

Simon Robertson 29 Jun 2024
Is Wellington still a great place to start up?
Opinion

Peter Griffin: Is Wellington still a great place to start up?

The startup community will have to take the lead in reviving the capital's tech vibe.

Peter Griffin 27 Jun 2024